Victoria Fan, Senior Fellow, Center for Global Development
Ole Norheim, Professor of Medical Ethics at University of Bergen, Norway and Adjunct Professor of Global Health at Harvard TH Chan School of Public Health
Gina Samaan, Unit Head, Pandemic Disease Preparedness, Epidemic and Pandemic Preparedness and Prevention Department, World Health Organization
What are the “best buys” of pandemic surveillance?
Understanding the costs and cost-effectiveness of surveillance interventions can strategically guide efforts in pandemic preparedness.
In this webinar, Senior Fellow Victoria Fan presents new CGD analysis examining what we know about the “best buys” of pandemic surveillance, followed by a conversation with experts who will share their experiences in preparedness.
While data on surveillance is very limited, evidence shows investing in four selected types of surveillance – laboratory networks, sentinel, notifiable disease, and health facility event-based – has potential for impact. But measures of effectiveness are not standardized, and the effectiveness of investments is not easily assessed.
To inform smart investments for the future, experts agree independent evaluation of investments in surveillance for preparedness is critical.